Search
for
Sort by
Research 121–150 of 1000+
- Efficacy and safety of janus kinase inhibitors in the treatment of alopecia areata in children
- Successful treatment of resistant alopecia totalis with tofacitinib
- <i>In‐silico</i> Screening of ATP‐competitive Inhibitory Activities of Phytochemicals against Janus Kinase 3 and Its <i>In‐vitro</i> Evaluation
- Janus kinase (JAK)
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Evaluating dermatologists’ knowledge of and attitudes toward Janus kinase inhibitor therapy for the treatment of alopecia areata
- A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- 44182 Treatment with Oral Janus Kinase Inhibitors in Adults Patients with Alopecia Areata: A Systematic Review and Meta-Analysis
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- 72751 Janus Kinase Inhibitors for Alopecia Universalis: A Systematic Review
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- INIBIDORES DA JANUS QUINASE PARA O TRATAMENTO DA ALOPECIA AREATA
- Baricitinib for alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Alopecia areata
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- THE USE OF TOFACITINIB IN THE TREATMENT OF IMMUNE-MEDIATED UNIVERSAL ALOPECIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT
- Ruxolitinib found to cause eyelash growth: a case report
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms